Advanced search
Publication Cover
Expert Opinion on Pharmacotherapy Volume 15, 2014 - Issue 8
Submit an article Journal homepage
822
Views
23
CrossRef citations to date
0
Altmetric
Reviews

Pharmacological management of polycystic kidney disease

Rudolf P WüthrichUniversity Hospital, Division of Nephrology, Rämistrasse 100, 8091 Zürich, Switzerland+41 44 255 33 84; +41 44 255 45 93; [email protected]
&
Changlin MeiSecond Military Medical University, Kidney Institute, Shanghai Changzheng Hospital, Department of Nephrology, Shanghai, PR China
Pages 1085-1095 | Published online: 28 Mar 2014

Citations (23)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Jacek Rysz, Anna Gluba-Brzózka, Beata Franczyk, Maciej Banach & Piotr Bartnicki. (2016) Combination drug versus monotherapy for the treatment of autosomal dominant polycystic kidney disease. Expert Opinion on Pharmacotherapy 17:15, pages 2049-2056.
Read now

Articles from other publishers (22)

Hajaralsadat Hosseini-Dastgerdi, Fatemeh Kharazmi, Ali-Asghar Pourshanazari & Mehdi Nematbakhsh. (2022) Renal Denervation Influences Angiotensin II Types 1 and 2 Receptors. International Journal of Nephrology 2022, pages 1-11.
Crossref
Haili Shi, Wouter N. Leonhard, Niels J. Sijbrandi, Mies J. van Steenbergen, Marcel H.A.M. Fens, Joep B. van de Dikkenberg, Javier Sastre Toraño, Dorien J.M. Peters, Wim E. Hennink & Robbert Jan Kok. (2019) Folate-dactolisib conjugates for targeting tubular cells in polycystic kidneys. Journal of Controlled Release 293, pages 113-125.
Crossref
Ying Jing, Ming Wu, Di Zhang, Dongping Chen, Ming Yang, Shuqin Mei, Liangliang He, Junhui Gu, Na Qi, Lili Fu, Lin Li & Changlin Mei. (2018) Triptolide delays disease progression in an adult rat model of polycystic kidney disease through the JAK2-STAT3 pathway. American Journal of Physiology-Renal Physiology 315:3, pages F479-F486.
Crossref
Anna S. Nikonova, Alexander Y. Deneka, Anna A. Kiseleva, Vladislav Korobeynikov, Anna Gaponova, Ilya G. Serebriiskii, Meghan C. Kopp, Harvey H. Hensley, Tamina N. Seeger‐Nukpezah, Stefan Somlo, David A. Proia & Erica A. Golemis. (2018) Ganetespib limits ciliation and cystogenesis in autosomal‐dominant polycystic kidney disease (ADPKD). The FASEB Journal 32:5, pages 2735-2746.
Crossref
Md Monirujjaman, Jessay G. Devassy, Tamio Yamaguchi, Nikhil Sidhu, Masanori Kugita, Melissa Gabbs, Shizuko Nagao, Jing Zhou, Amir Ravandi & Harold M. Aukema. (2017) Distinct oxylipin alterations in diverse models of cystic kidney diseases. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1862:12, pages 1562-1574.
Crossref
Johan Lorenzen & Rudolf P. Wüthrich. (2017) Autosomal-dominante polyzystische NierenerkrankungAutosomal dominant polycystic kidney disease. Der Nephrologe 12:4, pages 297-308.
Crossref
Xiaoying Lian, Jing Zhao, Xiaoyuan Wu, Yingjie Zhang, Qinggang Li, Shupeng Lin, Xue-Yuan Bai & Xiangmei Chen. (2017) The changes in glucose metabolism and cell proliferation in the kidneys of polycystic kidney disease mini-pig models. Biochemical and Biophysical Research Communications 488:2, pages 374-381.
Crossref
Qing Yao, Ming Wu, Jie Zhou, Meiyang Zhou, Dongping Chen, Lili Fu, Rongrong Bian, Xiaohong Xing, Lijun Sun, Xiaohong Hu, Lin Li, Bing Dai, Rudolf P. Wüthrich, Yiyi Ma & Chang-Lin Mei. (2017) Treatment of Persistent Gross Hematuria with Tranexamic Acid in Autosomal Dominant Polycystic Kidney Disease. Kidney and Blood Pressure Research 42:1, pages 156-164.
Crossref
Ming Wu, Junhui Gu, Shuqin Mei, Dechao Xu, Ying Jing, Qing Yao, Meihan Chen, Ming Yang, Sixiu Chen, Bo Yang, Na Qi, Huimin Hu, Rudolf P. W?thrich & Changlin Mei. (2016) Resveratrol delays polycystic kidney disease progression through attenuation of nuclear factor ?B-induced inflammation. Nephrology Dialysis Transplantation 31:11, pages 1826-1834.
Crossref
R. Wüthrich & M. Fischereder. (2016) Autosomal-dominante polyzystische NierenerkrankungAutosomal dominant polycystic kidney disease. Der Nephrologe 11:4, pages 268-274.
Crossref
Naser H. M. Ibrahim, Sijo J. Thandapilly, Yong Jia, Thomas Netticadan & Harold Aukema. (2015) Soy Protein Alleviates Hypertension and Fish Oil Improves Diastolic Heart Function in the Han:SPRD-Cy Rat Model of Cystic Kidney Disease. Lipids 51:5, pages 635-642.
Crossref
Meliana Riwanto, Sarika Kapoor, Daniel Rodriguez, Ilka Edenhofer, Stephan Segerer & Rudolf P. Wüthrich. (2016) Inhibition of Aerobic Glycolysis Attenuates Disease Progression in Polycystic Kidney Disease. PLOS ONE 11:1, pages e0146654.
Crossref
Claudia Sommerer & Martin Zeier. (2016) Clinical Manifestation and Management of ADPKD in Western Countries. Kidney Diseases 2:3, pages 120-127.
Crossref
Matthew D. Mason & John C. PopeIVIV. 2016. Congenital Anomalies of the Kidney and Urinary Tract. Congenital Anomalies of the Kidney and Urinary Tract 49 75 .
Mônica Souza de Miranda Henriques & Erick José de Morais Villar. 2015. Polycystic Kidney Disease. Polycystic Kidney Disease 425 441 .
Hannah A. Blair & Gillian M. Keating. (2015) Tolvaptan: A Review in Autosomal Dominant Polycystic Kidney Disease. Drugs 75:15, pages 1797-1806.
Crossref
R.P. W?thrich. (2015) Autosomal-dominante polyzystische NierenerkrankungAutosomal dominant polycystic kidney disease. Der Nephrologe 10:5, pages 376-378.
Crossref
Sarika Kapoor, Daniel Rodriguez, Meliana Riwanto, Ilka Edenhofer, Stephan Segerer, Katharyn Mitchell & Rudolf P. W?thrich. (2015) Effect of Sodium-Glucose Cotransport Inhibition on Polycystic Kidney Disease Progression in PCK Rats. PLOS ONE 10:4, pages e0125603.
Crossref
Daniel Rodriguez, Sarika Kapoor, Ilka Edenhofer, Stephan Segerer, Meliana Riwanto, Anja Kipar, Ming Yang, Changlin Mei & Rudolf P. Wüthrich. (2015) Inhibition of Sodium-GlucoseCotransporter 2 with Dapagliflozin in Han: SPRD Rats with Polycystic Kidney Disease. Kidney and Blood Pressure Research 40:6, pages 638-647.
Crossref
Naser H.M. Ibrahim, Melanie Gregoire, Jessay G. Devassy, Yinhong Wu, Daisuke Yoshihara, Tamio Yamaguchi, Shizuko Nagao & Harold M. Aukema. (2015) Cyclooxygenase product inhibition with acetylsalicylic acid slows disease progression in the Han:SPRD-Cy rat model of polycystic kidney disease. Prostaglandins & Other Lipid Mediators 116-117, pages 19-25.
Crossref
Zachary B. Smithline, Anna S. Nikonova, Harvey H. Hensley, Kathy Q. Cai, Brian L. Egleston, David A. Proia, Tamina Seeger-Nukpezah & Erica A. Golemis. (2014) Inhibiting Heat Shock Protein 90 (HSP90) Limits the Formation of Liver Cysts Induced by Conditional Deletion of Pkd1 in Mice. PLoS ONE 9:12, pages e114403.
Crossref
Cheng Xue, Chen-chen Zhou, Li-jun Sun, Liang-liang He, Cheng-gang Xu, Bing Dai & Chang-lin Mei. (2014) Effects of endothelial nitric oxide synthase gene on end stage renal disease progression in autosomal dominant polycystic kidney disease . Nephrology 19:10, pages 630-637.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.